60 degrees pharmaceuticals announces first quarter 2024 results

Q1 2024 net product revenues increased 515% year-over-year to $105.7 thousand. gross profit increased from ($55.9 thousand) to $51.0 thousand.
SXTP Ratings Summary
SXTP Quant Ranking